Charles A. Deignan, Chief Financial Officer at Clearside Biomedical, Inc. (CLSD), sold 12,900 shares at $1.28 ($17K) on 2024-01-19, disclosed to the SEC on 2024-01-19.
Seasonal sale ($17k) by Chief Financial Officer — this insider has traded CLSD in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| CLSD | SELL | 2021-09-23 | $18K | — | Filing → |
| CLSD | SELL | 2021-06-23 | $13K | — | Filing → |
| CLSD | SELL | 2020-06-03 | $28K | — | Filing → |